Skip to main content
main-content

Latest news

Breaking headlines, in-depth features, hot topic review articles, and 

the latest from major international conferences brought to you by

​​​​​​​

Editors' pick

08-16-2017 | Melanoma | News

Final BRIM-3 data confirm vemurafenib survival benefit over dacarbazine

Final data from the BRIM-3 trial show that overall survival remains significantly better with vemurafenib than with dacarbazine when given to treatment-naïve patients with BRAFV600 mutation–positive metastatic melanoma.

Source:

Ann Oncol 2017; Advance online publication

Latest headlines

08-18-2017 | Hematologic cancers | News

Azithromycin may increase post-HSCT hematologic malignancy relapse

A study investigating whether azithromycin improves airflow decline–free survival following allogeneic hematopoietic stem cell transplantation was terminated early due to an unexpected increased risk for hematologic malignancy relapse, researchers report.

Source:

JAMA 2017; 318: 557–566

08-17-2017 | EMA | Drug approval | News

approvalsWatch

Multiple orphan medications get nod from EMA

More details on these decisions available here

08-17-2017 | Pain | News

News in brief

Opioid use common in cancer survivors

A Canadian population-based study shows higher prescribing rates for opioids among cancer survivors than in individuals without a prior cancer diagnosis.

08-16-2017 | Stem cell transplantation | News

News in brief

Low vitamin D linked to increased relapse risk after HSCT for myeloid malignancies

Among patients with myeloid malignancies, vitamin D deficiency prior to undergoing allogeneic hematopoietic stem cell transplantation could affect disease control, find German researchers.

In depth

04-21-2017 | Lymphoma | Feature | Article

Lymphoma in practice: Professor Anas Younes speaks to medwireNews

Professor Anas Younes tells medwireNews about the current issues in lymphoma practice, both for the clinician and patients.

02-01-2017 | Patient-reported outcomes | Feature | Article

The time is right for patient-reported outcomes

medwireNews talks to Professor Dame Lesley Fallowfield and Dr Ethan Basch about the barriers to the routine incorporation of patient-reported outcomes in oncology clinical trials, and the changes that are happening.

Ask the expert

Are you a healthcare professional with questions about the management of oncology patients? Submit a question here and we'll put a selection of the best to our advisory board.

Calendar Upcoming events

Conference highlights

06-04-2017 | Collection

medwireNews@ASCO 2017

We provide coverage from the annual meeting of the American Society of Clinical Oncology, held in Chicago, Illinois, USA. Click through for news stories, conference reports, interviews and more.

02-03-2017 | Collection

ASH 2016

News from annual meeting of the American Society of Hematology, held in San Diego, California, USA. Click through to read the full reports.

02-01-2017 | Collection

ESMO 2016

News and conference reports from the ESMO 2016 Congress, held in Copenhagen, Denmark. Click through to read the full reports of the latest research.

Latest from us on Twitter

Updates from oncology organizations

image credits